Emalex Biosciences
Biotechnology ResearchView the employees at
Emalex Biosciences-
Chris Wilson API and DP Manufacturing | Technical Transfer | Manufacturing Scale-up | Analytical Development | Process Improvement
-
Raleigh-Durham-Chapel Hill Area
-
Top 10%
Chris Wilson API and DP Manufacturing | Technical Transfer | Manufacturing Scale-up | Analytical Development | Process Improvement-
Top 10%
Doug Frandsen Corporate Controller at Emalex Biosciences-
Greater Chicago Area
-
Rising Star
Overview
Emalex Biosciences, LLC is a biopharmaceutical company dedicated to the development of new treatments for rare and orphan neurological conditions. Ecopipam, its first development candidate, is a novel compound that has been studied as a potential treatment for many central nervous system (CNS) disorders, including pediatric Tourette Syndrome. The latter is a childhood-onset neurodevelopmental condition characterized by motor and vocal tics for which very few safe and effective therapies exist.
-